Try our beta test site
1 study found for:    14770429 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Drug: Sunitinib Malate (Sutent)

Study has passed its completion date and status has not been verified in more than two years.